NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Profusa, Inc. (PFSA) Stock Analysis

Profusa, Inc. (PFSA) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

PFSA

$0.85

−$0.04 (−4.05%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PFSA with… →

PFSA Key Statistics

As of Oct 21, 2026
Trading
Open
$0.86
Previous Close
$0.89
Day's Range
0.70–0.86
52-Week Range
0.70–3,000.00
Volume
214.51K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.50
Valuation
Market Cap
$514.32K
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$35.82M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
605.65K
1-Year Return
−99.85%
Dividend and dates
Avg Volume
2.81M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, PFSA closed at $0.85, −99.85% over 1 year.

Profusa, Inc. (PFSA) has a market capitalization of $514.32K.

In fiscal 2025, PFSA reported revenue of $0.00.

PFSA Stock Return by Calendar Year

Profusa, Inc. (PFSA) return since Jul 2025: what $10,000 became

1 year
$10,000 $15
−99.85%
Since Jul 2025
$10,000 $2
−99.98%

If you had invested $10,000 in Profusa, Inc. (PFSA) at the close on July 11, 2025, the earliest close on record here, it would have been worth $2 at the close on October 21, 2026: −99.98% in total, −99.88% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−99.57%
2025 (partial year)−95.80%

As of October 21, 2026.

PFSA Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$35.82M—
2024$0.00−$9.23M—
2023$0.00−$10.28M—
2022$0.00−$20.22M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$27.71M−$35.82M—
2024$0.00—−$4.50M−$9.23M—
2023$0.00—−$6.07M−$10.28M—
2022$0.00—−$9.44M−$20.22M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

Recent News

All 12 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Profusa, Inc. (PFSA) at $514.32K. It is classified in the Medical Devices industry, within the Healthcare sector.

PFSA last closed at $0.85 on October 21, 2026. That is −$0.04 (−4.05%) against the previous close. Over the past 52 weeks the price has ranged from $0.70 to $3,000.00. The latest close sits 21.31% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $0.00. The same year closed with a net loss of $35.82M.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

Over the trailing twelve months the total return is −99.85%. Beta against the wider market is reported at 0.5. Daily returns over the trailing 1 year annualize to a volatility of 696.73%.

Growth & Income

The record shows no dividend for PFSA.

So far in 2026 the total return is −99.57%.

Peer Comparison

Profusa, Inc. (PFSA) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Profusa, Inc. PFSA $514.32K —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Profusa, Inc.

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Visit website →